By proceeding, you agree to our Terms of Use and Privacy Policy.
Brendan Classon Executive Vice President of Research & Development at Parvus Therapeutics Inc
Talks About #researchdevelopment
Preferred Locations #NorthAmerica
The 6th Antigen-Specific Immune Tolerance Summit returns as the definitive industry-dedicated forum bringing you the latest discoveries, preclinical, translational, and early clinical developments on tolerogenic therapies.